CapitolRadar tracks every publicly disclosed TKNO trade by US congress members and corporate insiders: 30 disclosed trades (1 buys, 29 sells) by 1 tracked traders, from 2026-07-08 to 2026-08-12. Updated daily from official filings.
Want a ping when Congress buys TKNO? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
Alpha Teknova, Inc. (TKNO) — Healthcare · Drug Manufacturers - Specialty & Generic, market cap about $0.4B.
CapitolRadar analysis
10 sales, 0 purchases in the tracked record
10 tracked trades were disclosed for Alpha Teknova, Inc. (TKNO), all of them sales. The record contains 0 buys and 10 sells, producing a fully sell-only set of transactions. All 10 trades came from 1 distinct trader, so the activity reflects one person’s disclosed transactions rather than a broader pattern across multiple traders.
The tracked window runs from July 8, 2026 through July 16, 2026. Because the sample contains only 10 trades and 1 trader, it is small and highly concentrated. The data supports a description of the disclosed direction and frequency, but it does not establish a market-wide or group-wide view of TKNO.
2026 Q3 accounts for the full activity
10 trades appear in 2026 Q3, with 0 buys. That quarterly count matches the complete tracked total provided for TKNO, meaning all recorded activity in this dataset falls within the same quarter and consists exclusively of sales.
TKNO is Alpha Teknova, Inc., classified in Healthcare and the Drug Manufacturers - Specialty & Generic industry. No transaction amounts, exact prices, ownership changes, or reasons for the sales are provided, so those details cannot be assessed from this record.
Disclosure timing and amount caveats
Disclosed trading data can arrive with a reporting lag of up to 45 days, so filing dates and transaction dates should not be treated as real-time signals. Transaction values are also commonly reported as ranges; where amount ranges appear, estimated values are not exact dollar figures. In this case, no amount ranges were supplied. The combination of delayed reporting, absent transaction values, and a one-trader sample limits how broadly the 10 sales can be interpreted.
Analysis written from the tracked record on 2026-08-28; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2026 Q3 | 30 | 1 | 29 |
Who is buying TKNO?
| Trader | Disclosed buys | Last buy | Grade |
|---|---|---|---|
| Richard Blumenthal | 1 | 2026-08-10 | — |
Disclosed trades in TKNO
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2026-08-12 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-08-11 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-08-11 | Richard Blumenthal | sell | $15,001 - $50,000 | — |
| 2026-08-10 | Richard Blumenthal | buy | $1,001 - $15,000 | — |
| 2026-08-10 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-08-07 | Richard Blumenthal | sell | $15,001 - $50,000 | — |
| 2026-08-07 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-08-06 | Richard Blumenthal | sell | $15,001 - $50,000 | — |
| 2026-08-06 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-08-05 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-08-04 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-08-03 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-07-30 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-07-29 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-07-28 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-07-24 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-07-23 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-07-22 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-07-21 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
| 2026-07-20 | Richard Blumenthal | sell | $1,001 - $15,000 | — |
About Alpha Teknova, Inc.
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents …
Frequently asked questions
Which politicians bought TKNO most?
Richard Blumenthal leads with 1 disclosed buys.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.